EFTA01521097.pdf

GHISLAINE MAXWELL ACCT. For the Period 3/1/12 to 3/31/12 Account Summary Beginning Ending Change Estimated Current Asset Allocation Asset Allocation Market Value Market Value In Value Annual Income Allocation Equity 1,159,015.72 708,100.87 (450,914.85) 45,693.48 10% Alternative Assets 195,945.40 189,883.18 (6,062.22) 2% O0'pr Cash 8 Fixed Income 7,291,802.17 7,173,683.38 (118.118.79) 58,037.36 87% Other 90,156.84 89,407.23 (749.61) 1% Anomie* AMYL* Market Value 38.736820.13 38,161674.66 (3676,846.47) $103.730.84 100% equaY_ Accruals 31,96935 34948.43 2.579.08 Market Value with Accruals $8,768,989.42 $8,196,623.09 (3673,266.39) Cash& fixed bwonw Current Year4o•Date Portfolio Activity Period Value Value Beginning Market Value 8,736,920.13 4,926,904.29 Contributions 4972,947.20 Withdrawals 8 Fees (556,318.57) (2.079,617.24) Secunnes Transferred In 1,541,183.60 5,305,726.95 Securities Transferred Out (1.540.912.61) (5.203.158.62 Net Contributions/Withdrawals (0666,047.68) $2,995,898.29 Income 8. Distributions (2,711.81) 13,795.51 Change In Investment Value (17.086.08) 224.476.57 Ending Market Value $8,161,074.66 $8.161,074.66 Accruals 34.548 43 34.548 43 Market Value with Accruals $8.195.623.09 $8.195.623.09 JP Morgan Page 2 of 53 Confidential Treatment Requested by JPMorgan JPM-SDNY-00048457 Chase CONFIDENTIAL SDNY_GM_00317655 EFTA01521097